103 related articles for article (PubMed ID: 30927444)
21. The value of transvaginal sonography in detecting endometrial pathologies in postmenopausal women with or without bleeding.
Ates S; Sevket O; Sudolmus S; Ozel A; Molla T; Dane B; Dansuk R
Minerva Ginecol; 2014 Aug; 66(4):335-40. PubMed ID: 25020052
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of sonography for detecting endometrial pathologies in postmenopausal women with and without bleeding.
Seckin B; Cicek MN; Dikmen AU; Bostancı EI; Muftuoglu KH
J Clin Ultrasound; 2016 Jul; 44(6):339-46. PubMed ID: 26857098
[TBL] [Abstract][Full Text] [Related]
23. Ultrasonic thickness of the endometrium correlated to body weight in asymptomatic postmenopausal women.
Andolf E; Dahlander K; Aspenberg P
Obstet Gynecol; 1993 Dec; 82(6):936-40. PubMed ID: 8233268
[TBL] [Abstract][Full Text] [Related]
24. Endometrial changes with tamoxifen: comparison between tamoxifen-treated and nontreated asymptomatic, postmenopausal breast cancer patients.
Cohen I; Rosen DJ; Shapira J; Cordoba M; Gilboa S; Altaras MM; Yigael D; Beyth Y
Gynecol Oncol; 1994 Feb; 52(2):185-90. PubMed ID: 8314137
[TBL] [Abstract][Full Text] [Related]
25. The endometrium in asymptomatic breast cancer patients on tamoxifen: value of transvaginal ultrasonography with saline infusion and Doppler flow.
Develioğlu OH; Omak M; Bilgin T; Esmer A; Tüfekçi M
Gynecol Oncol; 2004 May; 93(2):328-35. PubMed ID: 15099941
[TBL] [Abstract][Full Text] [Related]
26. Role of postmenopausal bleeding pattern and women's age in the prediction of endometrial cancer.
Salman MC; Bozdag G; Dogan S; Yuce K
Aust N Z J Obstet Gynaecol; 2013 Oct; 53(5):484-8. PubMed ID: 23909869
[TBL] [Abstract][Full Text] [Related]
27. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound.
Gerber B; Krause A; Müller H; Reimer T; Külz T; Makovitzky J; Kundt G; Friese K
J Clin Oncol; 2000 Oct; 18(20):3464-70. PubMed ID: 11032586
[TBL] [Abstract][Full Text] [Related]
28. Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy.
McGonigle KF; Shaw SL; Vasilev SA; Odom-Maryon T; Roy S; Simpson JF
Am J Obstet Gynecol; 1998 Jun; 178(6):1145-50. PubMed ID: 9662294
[TBL] [Abstract][Full Text] [Related]
29. [Transvaginal sonography of the postmenopausal endometrium].
Curcić A; Segedi D; Belopavlović Z; Petrović D
Med Pregl; 2000; 53(1-2):59-63. PubMed ID: 10953553
[TBL] [Abstract][Full Text] [Related]
30. Three-dimensional ultrasound imaging for discrimination between benign and malignant endometrium in women with postmenopausal bleeding and sonographic endometrial thickness of at least 4.5 mm.
Opolskiene G; Sladkevicius P; Jokubkiene L; Valentin L
Ultrasound Obstet Gynecol; 2010 Jan; 35(1):94-102. PubMed ID: 19902471
[TBL] [Abstract][Full Text] [Related]
31. Screening transvaginal uterine ultrasonography for identifying endometrial pathology in postmenopausal women.
Paraskevaidis E; Papadimitriou D; Kalantaridou SN; Pappa L; Malamou-Mitsi V; Zikopoulos K; Kazantzis E; Lolis ED; Agnantis NJ
Anticancer Res; 2002; 22(4):2517-20. PubMed ID: 12174954
[TBL] [Abstract][Full Text] [Related]
32. The effect of tamoxifen on the endometrium, serum lipids and hypothalamus pituitary axis in the postmenopausal breast cancer patients.
Kavak ZN; Binöz S; Ceyhan N; Pekin S
Acta Obstet Gynecol Scand; 2000 Jul; 79(7):604-7. PubMed ID: 10929963
[TBL] [Abstract][Full Text] [Related]
33. The role of endometrial thickness for detecting endometrial pathologies in asymptomatic postmenopausal women.
Saatli B; Yildirim N; Olgan S; Koyuncuoglu M; Emekci O; Saygılı U
Aust N Z J Obstet Gynaecol; 2014 Feb; 54(1):36-40. PubMed ID: 24471845
[TBL] [Abstract][Full Text] [Related]
34. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
Cheng WF; Lin HH; Torng PL; Huang SC
Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568
[TBL] [Abstract][Full Text] [Related]
35. Transvaginal ultrasonographic measurement of endometrial thickness in postmenopausal women receiving estrogen replacement therapy.
Holbert TR
Am J Obstet Gynecol; 1997 Jun; 176(6):1334-8; discussion 1338-9. PubMed ID: 9215193
[TBL] [Abstract][Full Text] [Related]
36. An assessment of the value of ultrasonographic screening for endometrial disease in postmenopausal women without symptoms.
Fleischer AC; Wheeler JE; Lindsay I; Hendrix SL; Grabill S; Kravitz B; MacDonald B
Am J Obstet Gynecol; 2001 Jan; 184(2):70-5. PubMed ID: 11174482
[TBL] [Abstract][Full Text] [Related]
37. Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study.
Exacoustos C; Zupi E; Cangi B; Chiaretti M; Arduini D; Romanini C
Ultrasound Obstet Gynecol; 1995 Dec; 6(6):435-42. PubMed ID: 8903921
[TBL] [Abstract][Full Text] [Related]
38. Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis.
Pinkerton JV; Archer DF; Utian WH; Menegoci JC; Levine AB; Chines AA; Constantine GD
Menopause; 2009; 16(6):1102-8. PubMed ID: 19546825
[TBL] [Abstract][Full Text] [Related]
39. Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen.
Mourits MJ; Van der Zee AG; Willemse PH; Ten Hoor KA; Hollema H; De Vries EG
Gynecol Oncol; 1999 Apr; 73(1):21-6. PubMed ID: 10094875
[TBL] [Abstract][Full Text] [Related]
40. Surveillance for endometrial cancer in postmenopausal breast cancer patients taking tamoxifen.
Sinawat S; Chiyabutra T; Kleabkaew P
Asian Pac J Cancer Prev; 2003; 4(4):327-30. PubMed ID: 14728591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
